We found no significant effect of TLR activation on human AD-MSC-mediated suppression, indicating that activation through TLR2, TLR3, and TLR4 do not significantly interfere with the capacity of human AD-MSCs to modulate immune responses in vitro. This evidence concerns the gene TLR2 and Alzheimer disease.